Portage Biotech (PRTG) Competitors $6.02 +0.14 (+2.31%) Closing price 03:59 PM EasternExtended Trading$6.02 0.00 (-0.02%) As of 04:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRTG vs. CARA, TENX, CYTH, CALC, BCAB, GBIO, FBLG, FGEN, NNVC, and ELEVShould you be buying Portage Biotech stock or one of its competitors? The main competitors of Portage Biotech include Cara Therapeutics (CARA), Tenax Therapeutics (TENX), Cyclo Therapeutics (CYTH), CalciMedica (CALC), BioAtla (BCAB), Generation Bio (GBIO), FibroBiologics (FBLG), FibroGen (FGEN), NanoViricides (NNVC), and Elevation Oncology (ELEV). These companies are all part of the "pharmaceutical products" industry. Portage Biotech vs. Its Competitors Cara Therapeutics Tenax Therapeutics Cyclo Therapeutics CalciMedica BioAtla Generation Bio FibroBiologics FibroGen NanoViricides Elevation Oncology Portage Biotech (NASDAQ:PRTG) and Cara Therapeutics (NASDAQ:CARA) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership. Which has more risk & volatility, PRTG or CARA? Portage Biotech has a beta of 0.23, indicating that its share price is 77% less volatile than the S&P 500. Comparatively, Cara Therapeutics has a beta of 0.41, indicating that its share price is 59% less volatile than the S&P 500. Is PRTG or CARA more profitable? Portage Biotech has a net margin of 0.00% compared to Cara Therapeutics' net margin of -1,099.76%. Portage Biotech's return on equity of 0.00% beat Cara Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Portage BiotechN/A N/A N/A Cara Therapeutics -1,099.76%-367.97%-107.43% Which has higher earnings and valuation, PRTG or CARA? Portage Biotech has higher earnings, but lower revenue than Cara Therapeutics. Portage Biotech is trading at a lower price-to-earnings ratio than Cara Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPortage BiotechN/AN/A-$75.34M-$41.65-0.14Cara Therapeutics$7.14M0.00-$118.51M-$21.01N/A Do insiders & institutionals believe in PRTG or CARA? 13.4% of Portage Biotech shares are held by institutional investors. Comparatively, 44.7% of Cara Therapeutics shares are held by institutional investors. 42.1% of Portage Biotech shares are held by company insiders. Comparatively, 3.1% of Cara Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media favor PRTG or CARA? In the previous week, Portage Biotech's average media sentiment score of 0.00 equaled Cara Therapeutics'average media sentiment score. Company Overall Sentiment Portage Biotech Neutral Cara Therapeutics Neutral SummaryPortage Biotech beats Cara Therapeutics on 6 of the 10 factors compared between the two stocks. Get Portage Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRTG vs. The Competition Export to ExcelMetricPortage BiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.32M$2.96B$5.57B$9.02BDividend YieldN/A2.44%5.25%4.03%P/E Ratio-0.1421.1627.2120.15Price / SalesN/A260.59416.26185.35Price / Cash0.7341.8337.0657.97Price / Book1.617.768.085.60Net Income-$75.34M-$54.96M$3.16B$248.50M7 Day Performance2.66%5.99%3.74%5.11%1 Month Performance-22.67%4.41%3.88%7.58%1 Year Performance77.36%6.36%34.26%21.53% Portage Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRTGPortage Biotech0.6808 of 5 stars$6.02+2.3%N/A+94.3%$6.32MN/A-0.146CARACara Therapeutics0.3594 of 5 starsN/AN/AN/A$24.33M$7.14M-0.2580Gap DownHigh Trading VolumeTENXTenax Therapeutics1.2779 of 5 stars$5.80+0.9%$17.50+201.7%+85.4%$24.06MN/A-2.349CYTHCyclo TherapeuticsN/A$0.72flat$0.95+31.8%N/A$23.72M$870.73K-0.809CALCCalciMedica3.2188 of 5 stars$1.64+1.6%$18.00+1,000.2%-63.7%$22.98MN/A-1.0530BCABBioAtla2.5478 of 5 stars$0.39+1.8%$5.00+1,172.3%-66.9%$22.96M$11M-0.3260Gap UpGBIOGeneration Bio3.4605 of 5 stars$0.34+3.6%$7.33+2,044.2%-84.1%$22.93M$19.89M-0.32150FBLGFibroBiologics2.8459 of 5 stars$0.59-1.8%$13.00+2,088.6%-86.6%$22.73MN/A-2.8310News CoverageAnalyst ForecastFGENFibroGen4.6468 of 5 stars$5.58+3.9%$250.00+4,380.3%-70.5%$22.54M$29.62M-2.23570Positive NewsNNVCNanoViricides1.1088 of 5 stars$1.39+0.7%N/A-20.0%$22.34MN/A-1.9320Positive NewsELEVElevation Oncology1.7628 of 5 stars$0.38-0.8%$3.39+800.5%-85.5%$22.27MN/A-0.4640 Related Companies and Tools Related Companies Cara Therapeutics Alternatives Tenax Therapeutics Alternatives Cyclo Therapeutics Alternatives CalciMedica Alternatives BioAtla Alternatives Generation Bio Alternatives FibroBiologics Alternatives FibroGen Alternatives NanoViricides Alternatives Elevation Oncology Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRTG) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredHow a Kansas farm boy gained 1,285% in two daysA former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a...TradeSmith | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting—or plan to collect—Social Security, this could be a game-changer. A new initiative tie...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Portage Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Portage Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRTG Stock Alerts